Raymond James Financial’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7.02K	Buy	+2,629	New	+$7.02K	﹤0.01%	5974
2025 Q1	–	Sell	-2,630	Closed	-$25.4K	–	4884
2024 Q4	$25.4K	Buy	+2,630	New	+$25.4K	﹤0.01%	4638